CClinicalTrials.gg
Enrolling by invitationNCT06623149Updated Jun 16, 2026

Conservative Management vs. Arthroplasty in Knee Osteoarthritis

An observational study in Knee Osteoarthrosis, sponsored by Marius Henriksen. Enrolling by invitation at 6 sites in Denmark. Per ClinicalTrials.gov, last updated 2026-06-16.

Sponsored by Marius Henriksen · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
2,500
Sex
All
01

Study summary

The goal of this observational study is to learn about the long-term effects of a non-surgical management programme in people with osteoarthritis that are eligible for a knee joint replacement surgery to treat their knee osteoarthritis (KOA). The main question it aims to answer is:

- Does the non-surgical management programme reduce the proportion of referred patients who are treated with a knee arthroplasty without reducing the health-related quality of life over a two-year perspective?

Read the detailed description

Knee arthroplasty (joint replacement surgery) is a well-established and effective treatment for knee osteoarthritis (KOA). The incidence of knee arthroplasty has increased in Denmark from 8,000 procedures in 2017 to over 15,000 in 2023, partly due to demographic changes, demands, and the procedures effectiveness. However, concerns remain that some patients undergo surgery without having fully explored non-surgical options.

A growing body of research and public declarations suggest that individuals with KOA may benefit from conservative treatment regimens encompassing physical training, weight loss, and pain management strategies. It is implicitly suggested that surgical procedures may be circumvented or deferred well beyond the span of these conservative measures, without adversely impacting patients' quality of life. Such contentions have garnered the attention of decision-makers in the policy realm.

Consequently, a task force under the Capital Region of Denmark has recently mandated a policy shift requiring public hospitals to establish pathways for conservative, non-operative treatment with a duration of three months that patients must complete prior to considering knee arthroplasty. The aim of this policy alteration is to further prioritize conservative management and curtail the frequency of knee arthroplasty procedures while preserving patients' quality of life. Although the number of surgical procedures could be ostensibly minimized by constraining healthcare service provisions and impeding patient access, the patients' quality of life remains the paramount political objective. Consequently, the task force has decided to assess the impact of the policy change by endorsing and initiating a study to monitor quality, as summarized in the current protocol synopsis.

The new policy is introduced in a step-wise manner at the major hospitals in the Capital Region of Denmark (Copenhagen) from October 1st 2024 to January 1st 2025) and this observational study enrols patients at the hospitals before and after implementation of the new policy to facilitate a comparison of the two policies (new vs old). The enrolled patients are followed for 2 years with regular collection of patient-reported outcomes and medical record reviews.

02

Conditions studied

  • Knee Osteoarthrosis

Keywords

  • arthroplasty
  • exercise
  • osteoarthritis
  • weight loss
  • pain management
  • quality of ilfe
03

In context

Osteoarthritis, Knee

3,302 studies on the registry are indexed under Osteoarthritis, Knee; 608 are open to participants now.

This study's planned enrollment of 2,500 is above the median of 100 across 472 observational studies indexed under Osteoarthritis, Knee.

Browse Osteoarthritis, Knee studies →

Lead sponsor

Marius Henriksen is the lead sponsor of 18 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All patients referred to an orthopedic department at a hospital in The Capital Region of Denmark for treatment of knee osteoarthritis.

Inclusion criteria

  • A diagnosis of knee osteoarthritis.
  • Referral from primary care to an orthopedic department at a hospital in The Capital Region of Denmark for treatment of knee osteoarthritis

Exclusion criteria

Exclusion Criteria:

  • Referral declined upon initial vetting.
  • Not consenting to sharing data
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
2,500 participants (estimated)
Patient registry
No

Groups and cohorts

  • Old policy

    Individuals with knee osteoarthritis referred from a general practitioner to a participating orthopedic department for assessment of eligibility for knee arthroplasty (surgical joint replacement).

    Procedure: Current practice

  • New policy - non-surgical management

    Individuals with knee osteoarthritis referred from a general practitioner to a participating orthopedic department for assessment of eligibility for knee arthroplasty (surgical joint replacement).

    Behavioral: Non-Surgical Intervention

Interventions

  • BehavioralNon-Surgical Intervention

    After referral from the general practitioner to the orthopedic department, the patient is offered a 3-month non-operative treatment program. The conservative program consists of several elements that are offered on an individual basis. The program consists of 3 main elements: * Patient education/information * Specialized exercise supervised by a physiotherapist * Weight loss counseling with a dietician

  • ProcedureCurrent practice

    After referral from the general practitioner to the orthopedic department, the patient is assessed by an orthopedic surgeon in the out-patient clinic according to standard practice with a focus on symptoms, history, physical examination, radiography, and an appraisal of the patient's expectations. If an indication for knee arthroplasty is found, the patient is offered knee arthroplasty, and if the patient accepts the offer, he/she is scheduled according to usual practice. If a patient declines the offer, the patient is informed that the hospital cannot offer any additional service, and the patient is referred back to primary care.

06

What researchers measure

Primary outcomes

  1. Proportion of patients undergoing knee arthroplasty surgery

    Percentage of patients who undergo knee replacement surgery in the target joint during the 2-year observation period.

    Time frame: 2 years

  2. Euroqol 5 dimensions questionnaire (EQ5D)

    EQ5D is a standardized patient-reported instrument for use as a measure of health outcome and quality of life. EQ5D is designed for self-completion by respondents and is ideally suited for use in surveys. We will use standard Danish value set to convert the five EQ-5D-5L answers to a single index utility score, and ulti-mately to calculate the QALYs gained by the treatment.

    Time frame: Average over 2 years (collected at month 0 (enrollment), 3, 6, 9, 12, 18 and 24)

Secondary outcomes

  1. Oxford Knee Score questionnaire

    The Oxford Knee Score (OKS) is a 12-item Patient Reported Outcome questionnaire developed specifically to assess the patients perspective on the outcomes of knee arthroplasty with respect to combined pain and physical function. Standardized answer options are given (5 Likert boxes) and each question is assigned a score from 0 to 4. Thus, a total score is calculated that ranges from 0 and 48, with 48 indicating the best outcome.

    Time frame: Average over 2 years (collected at month 0 (enrollment), 3, 6, 9, 12, 18 and 24)

  2. Oxford Knee Score questionnaire

    The Oxford Knee Score (OKS) is a 12-item Patient Reported Outcome questionnaire developed specifically to assess the patients perspective on the outcomes of knee arthroplasty with respect to combined pain and physical function. Standardized answer options are given (5 Likert boxes) and each question is assigned a score from 0 to 4. Thus, a total score is calculated that ranges from 0 and 48, with 48 indicating the best outcome.

    Time frame: After 2 years (month 24)

  3. Euroqol 5 dimensions questionnaire (EQ5D)

    EQ5D is a standardized patient-reported instrument for use as a measure of health outcome and quality of life. EQ5D is designed for self-completion by respondents and is ideally suited for use in surveys. We will use standard Danish value set to convert the five EQ-5D-5L answers to a single index utility score, and ulti-mately to calculate the QALYs gained by the treatment.

    Time frame: After 2 years (month 24)

  4. Satisfaction questionnaire

    A 5-item questionaire for satisfaction focusing on satisfaction with function of the knee, and the received treatment.

    Time frame: After 1 year (month 12)

  5. Satisfaction questionnaire

    A 5-item questionaire for satisfaction focusing on satisfaction with function of the knee, and the received treatment.

    Time frame: After 2 years (month 24)

  6. UCLA Physical Activity Scale

    The UCLA Activity Scale is a questionnaire used to assess the physical activity levels of patients, particularly those with joint issues, such as knee osteoarthritis or those who have undergone knee arthroplasty. It ranges from 1 to 10, with higher scores indicating higher levels of physical activity. This scale helps clinicians evaluate the functional status of patients and their capacity to perform various physical activities.

    Time frame: Change from baseline after 2 years (month 24)

  7. UCLA Physical Activity Scale

    The UCLA Activity Scale is a questionnaire used to assess the physical activity levels of patients, particularly those with joint issues, such as knee osteoarthritis or those who have undergone knee arthroplasty. It ranges from 1 to 10, with higher scores indicating higher levels of physical activity. This scale helps clinicians evaluate the functional status of patients and their capacity to perform various physical activities.

    Time frame: Change from baseline after 1 year (month 12)

  8. Copenhagen Knee Range of Motion Scale

    The Copenhagen Knee Range of Motion Scale is a clinical tool used to assess and quantify the range of motion in the knee joint. It is particularly useful for evaluating patients with knee osteoarthritis, those undergoing rehabilitation, or those recovering from knee surgeries such as arthroplasty. This scale measures the patient's ability to bend the knee (flexion) and the ability to straighten the knee (extension). The Copenhagen Knee ROM Scale provides a standardized method for healthcare professionals to record knee movement, track progress over time, and guide treatment decisions.

    Time frame: After 1 year (month 12)

  9. Copenhagen Knee Range of Motion Scale

    The Copenhagen Knee Range of Motion Scale is a clinical tool used to assess and quantify the range of motion in the knee joint. It is particularly useful for evaluating patients with knee osteoarthritis, those undergoing rehabilitation, or those recovering from knee surgeries such as arthroplasty. This scale measures the patient's ability to bend the knee (flexion) and the ability to straighten the knee (extension). The Copenhagen Knee ROM Scale provides a standardized method for healthcare professionals to record knee movement, track progress over time, and guide treatment decisions.

    Time frame: After 2 years (month 24)

Other outcomes

  1. Proportion of patients undergoing knee arthroplasty surgery

    Percentage of patients who undergo knee replacement surgery in the target joint over a 5-year observation period.

    Time frame: 5 years

  2. Costs

    Total expenses on healthcare (direct and indirect costs) from enrollment to 2-years

    Time frame: During 2 year from enrollment

07

Study locations

6 sites
  • Bispebjerg Frederiksberg Hospital
    Copenhagen, Copenhagen 2000, Denmark
  • Amager Hvidovre Hospital
    Copenhagen, Hvidovre 2650, Denmark
  • Rigshospitalet
    Copenhagen, 2100, Denmark
  • herlev Gentofe Hospital
    Copenhagen, 2730, Denmark
  • Nordsjællands Hospital
    Hillerød, 3400, Denmark
  • Bornholms hospital
    Rønne, Denmark
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06623149
Lead sponsor
Marius Henriksen
Responsible party
Marius Henriksen (Professor, Frederiksberg University Hospital) — Sponsor-investigator
First posted
Oct 2, 2024
Start date
Oct 1, 2024
Primary completion
Apr 30, 2027 (estimated)
Completion
Apr 2030 (estimated)
Last update
Jun 16, 2026

Study contacts

Marius Henriksen, Professor
study chair · The Parker Institute, Bispebjerg Frederiksberg University Hospital, Copenhagen, Denmark
Anders Odgaard, Professor
study chair · Rigshospitalet, Denmark

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion